Tallantyre, Emma C.  ORCID: https://orcid.org/0000-0002-3760-6634
2022.
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk ? No.
Multiple Sclerosis Journal
28
(8)
, pp. 1175-1177.
10.1177/13524585221091404
|
Preview |
PDF
- Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (174kB) | Preview |
Official URL: http://dx.doi.org/10.1177/13524585221091404
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) |
| Publisher: | SAGE Publications |
| ISSN: | 1352-4585 |
| Date of First Compliant Deposit: | 8 June 2022 |
| Date of Acceptance: | 14 March 2022 |
| Last Modified: | 19 Nov 2024 21:00 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/150297 |
Citation Data
Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Dimensions
Dimensions